CINNAMON

CINNAMON was reported 3353 times

CINNAMON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHOLESTEROLOSIS BULBI 2 0.4000
1 ADMINISTRATION SITE DISCOLOURATION 2 0.0160
2 INTERSTITIAL GRANULOMATOUS DERMATITIS 3 0.0155
3 BODY MASS INDEX ABNORMAL 2 0.0082
4 BREAST DISORDER FEMALE 2 0.0078
5 GENITAL ABSCESS 3 0.0074
6 VITAMIN B12 INCREASED 5 0.0063
7 AMINO ACID LEVEL DECREASED 2 0.0059
8 BONE FRAGMENTATION 3 0.0054
9 LIFE SUPPORT 3 0.0053
10 CAT SCRATCH DISEASE 2 0.0050
11 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
12 BLADDER HYPERTROPHY 2 0.0045
13 BLOOD CHROMOGRANIN A INCREASED 2 0.0044
14 BIOPSY BONE MARROW 2 0.0043
15 PARASOMNIA 3 0.0042
16 BODY FAT DISORDER 2 0.0037
17 POST PROCEDURAL SWELLING 4 0.0036
18 CARDIAC STRESS TEST ABNORMAL 3 0.0036
19 PERIORBITAL PAIN 3 0.0035
20 MALIGNANT HYPERTENSION 3 0.0035
21 BLADDER IRRITATION 2 0.0031
22 BLOOD IMMUNOGLOBULIN A DECREASED 2 0.0031
23 CHRONIC MYELOMONOCYTIC LEUKAEMIA 2 0.0030
24 IMPLANTABLE DEFIBRILLATOR INSERTION 4 0.0030
25 VASCULAR CALCIFICATION 3 0.0028
26 AMINO ACID LEVEL INCREASED 2 0.0027
27 LIGAMENT INJURY 3 0.0026
28 CARBOHYDRATE ANTIGEN 125 INCREASED 9 0.0026
29 NEPHROGENIC ANAEMIA 12 0.0026
30 AORTIC DISORDER 2 0.0025
31 CARTILAGE ATROPHY 2 0.0025
32 BLOOD TRIGLYCERIDES ABNORMAL 2 0.0023
33 ANIMAL SCRATCH 2 0.0021
34 HYPERPARATHYROIDISM SECONDARY 5 0.0020
35 BRAIN HYPOXIA 2 0.0020
36 GLYCOSYLATED HAEMOGLOBIN DECREASED 3 0.0019
37 SKIN WRINKLING 5 0.0018
38 HAEMORRHAGIC ANAEMIA 8 0.0018
39 COLONIC POLYP 3 0.0018
40 COLONOSCOPY 4 0.0018
41 BENIGN NEOPLASM 2 0.0018
42 AORTIC THROMBOSIS 2 0.0017
43 INFUSION SITE DISCHARGE 3 0.0017
44 BLADDER PROLAPSE 2 0.0016
45 CAROTID ARTERY DISEASE 2 0.0016
46 HYPOGEUSIA 3 0.0015
47 BODY MASS INDEX INCREASED 2 0.0015
48 EYELID PAIN 3 0.0015
49 DIABETIC RETINOPATHY 5 0.0015
50 CHANGE OF BOWEL HABIT 3 0.0015
51 CERVICAL VERTEBRAL FRACTURE 5 0.0014
52 VIITH NERVE PARALYSIS 5 0.0014
53 CATAPLEXY 2 0.0014
54 BLOOD ELECTROLYTES DECREASED 2 0.0014
55 DANDRUFF 3 0.0014
56 TONGUE BLISTERING 3 0.0013
57 CHRONIC SINUSITIS 5 0.0013
58 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
59 REBOUND ACID HYPERSECRETION 4 0.0013
60 LOSS OF CONTROL OF LEGS 5 0.0013
61 READING DISORDER 3 0.0013
62 MENOPAUSAL SYMPTOMS 3 0.0013
63 MEDICATION RESIDUE PRESENT 6 0.0013
64 TENDON DISORDER 8 0.0012
65 TRIGGER FINGER 5 0.0012
66 INFUSION SITE HAEMORRHAGE 4 0.0012
67 DIABETIC NEUROPATHY 6 0.0012
68 POST-TRAUMATIC STRESS DISORDER 8 0.0012
69 DECREASED INTEREST 7 0.0012
70 CATARACT OPERATION 7 0.0012
71 VITAMIN D DECREASED 10 0.0012
72 WOUND COMPLICATION 4 0.0012
73 MENOPAUSE 3 0.0012
74 TACHYPHRENIA 4 0.0012
75 URINE OUTPUT INCREASED 3 0.0011
76 MULTIPLE ALLERGIES 9 0.0011
77 EAR PRURITUS 4 0.0011
78 BLOOD POTASSIUM ABNORMAL 3 0.0011
79 BREAST SWELLING 3 0.0011
80 FLUSHING 112 0.0011
81 EXOSTOSIS 10 0.0011
82 HYPERKERATOSIS 6 0.0011
83 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
84 ROSACEA 5 0.0011
85 BLADDER SPASM 2 0.0011
86 DYSGRAPHIA 7 0.0011
87 SNORING 4 0.0011
88 LIP PAIN 3 0.0010
89 THYROID MASS 4 0.0010
90 FAECAL INCONTINENCE 5 0.0010
91 BLOOD URIC ACID INCREASED 6 0.0010
92 RENAL PAIN 11 0.0010
93 SKIN WARM 6 0.0010
94 SENSATION OF HEAVINESS 4 0.0010
95 PULMONARY PAIN 3 0.0010
96 HYPERPHAGIA 4 0.0010
97 TRIGEMINAL NEURALGIA 4 0.0010
98 APPLICATION SITE DISCOLOURATION 4 0.0010
99 DEMYELINATION 4 0.0010
100 TENDERNESS 10 0.0010
101 GLYCOSYLATED HAEMOGLOBIN INCREASED 24 0.0009
102 BREAST CANCER RECURRENT 3 0.0009
103 NON-CARDIAC CHEST PAIN 3 0.0009
104 TESTICULAR PAIN 3 0.0009
105 BILE DUCT STONE 3 0.0009
106 PNEUMONIA VIRAL 3 0.0009
107 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
108 LOOSE TOOTH 3 0.0009
109 BLOOD TESTOSTERONE INCREASED 2 0.0009
110 HYPERLIPIDAEMIA 11 0.0009
111 MELANOCYTIC NAEVUS 4 0.0009
112 ONYCHOMYCOSIS 4 0.0009
113 SPINAL OSTEOARTHRITIS 8 0.0009
114 WALKING AID USER 6 0.0009
115 NEAR DEATH EXPERIENCE 3 0.0009
116 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
117 GOUT 16 0.0009
118 SUPRAVENTRICULAR EXTRASYSTOLES 3 0.0009
119 GINGIVAL PAIN 7 0.0009
120 ONYCHOCLASIS 6 0.0009
121 LEFT VENTRICULAR FAILURE 3 0.0009
122 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
123 ROTATOR CUFF SYNDROME 11 0.0009
124 NECROTISING FASCIITIS 3 0.0009
125 VAGINAL INFECTION 4 0.0008
126 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
127 HAIR DISORDER 7 0.0008
128 SEASONAL ALLERGY 12 0.0008
129 DIVERTICULUM 6 0.0008
130 HAEMORRHAGIC DIATHESIS 3 0.0008
131 BODY HEIGHT DECREASED 9 0.0008
132 BONE LESION 3 0.0008
133 RASH VESICULAR 4 0.0008
134 MONOCYTE COUNT INCREASED 3 0.0008
135 DIZZINESS POSTURAL 8 0.0008
136 BRONCHITIS CHRONIC 2 0.0008
137 RENAL CELL CARCINOMA 4 0.0008
138 CHRONIC KIDNEY DISEASE 62 0.0008
139 DENTAL CARIES 9 0.0008
140 WOUND HAEMORRHAGE 3 0.0008
141 HYPERVOLAEMIA 4 0.0008
142 TENDON INJURY 3 0.0008
143 HYPERACUSIS 3 0.0008
144 ABDOMINAL TENDERNESS 4 0.0008
145 ANEURYSM 4 0.0008
146 PROTEIN URINE PRESENT 4 0.0008
147 DERMATITIS EXFOLIATIVE 4 0.0008
148 AUTOIMMUNE THYROIDITIS 3 0.0008
149 FLATULENCE 45 0.0008
150 PARANASAL SINUS DISCOMFORT 3 0.0008
151 FACE INJURY 3 0.0008
152 VULVOVAGINAL PRURITUS 4 0.0008
153 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
154 PERIPHERAL VASCULAR DISORDER 4 0.0008
155 TEMPERATURE INTOLERANCE 8 0.0008
156 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
157 ACTINIC KERATOSIS 2 0.0008
158 ORAL INFECTION 3 0.0008
159 BLOOD GLUCOSE ABNORMAL 14 0.0008
160 BALANCE DISORDER 65 0.0008
161 OBSTRUCTION 3 0.0008
162 SKIN MASS 5 0.0007
163 FOOD POISONING 4 0.0007
164 ABDOMINAL MASS 2 0.0007
165 OVERWEIGHT 4 0.0007
166 LOCALISED INFECTION 18 0.0007
167 FUNGAL SKIN INFECTION 3 0.0007
168 POST PROCEDURAL INFECTION 6 0.0007
169 COLD SWEAT 13 0.0007
170 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
171 CLUMSINESS 2 0.0007
172 APPLICATION SITE EXFOLIATION 3 0.0007
173 DEAFNESS UNILATERAL 4 0.0007
174 LYMPHOEDEMA 5 0.0007
175 THYROID FUNCTION TEST ABNORMAL 3 0.0007
176 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
177 CHOLECYSTITIS INFECTIVE 2 0.0007
178 SECRETION DISCHARGE 9 0.0007
179 HEART RATE ABNORMAL 4 0.0007
180 CARPAL TUNNEL SYNDROME 10 0.0007
181 TENDONITIS 11 0.0007
182 URINARY INCONTINENCE 21 0.0007
183 SINUS DISORDER 14 0.0007
184 CHOLECYSTITIS ACUTE 4 0.0007
185 BLOOD PRESSURE ABNORMAL 14 0.0007
186 PERONEAL NERVE PALSY 4 0.0007
187 DERMATITIS CONTACT 8 0.0007
188 SCAB 8 0.0007
189 CARDIAC VALVE DISEASE 4 0.0007
190 SKIN ATROPHY 4 0.0007
191 CHAPPED LIPS 3 0.0007
192 TONGUE DISORDER 5 0.0007
193 SCIATICA 11 0.0007
194 MOTOR DYSFUNCTION 7 0.0007
195 BLOOD URINE PRESENT 13 0.0007
196 BLOOD CALCIUM INCREASED 6 0.0007
197 TYPE 2 DIABETES MELLITUS 23 0.0007
198 TOOTH INFECTION 9 0.0007
199 SLEEP APNOEA SYNDROME 13 0.0007
200 INTENTIONAL DEVICE MISUSE 3 0.0007
201 HOT FLUSH 51 0.0007
202 WHEELCHAIR USER 3 0.0007
203 SUNBURN 5 0.0007
204 WEIGHT FLUCTUATION 7 0.0007
205 ATYPICAL PNEUMONIA 2 0.0007
206 HAEMORRHOIDS 13 0.0007
207 SCRATCH 7 0.0007
208 CENTRAL VENOUS CATHETERISATION 2 0.0007
209 INCONTINENCE 7 0.0007
210 ABDOMINAL HERNIA 3 0.0007
211 VULVOVAGINAL BURNING SENSATION 4 0.0007
212 EYE OPERATION 3 0.0007
213 SCOLIOSIS 4 0.0006
214 FULL BLOOD COUNT DECREASED 13 0.0006
215 PULMONARY THROMBOSIS 7 0.0006
216 NEUROPATHY PERIPHERAL 61 0.0006
217 BLOOD BLISTER 2 0.0006
218 BLOOD GLUCOSE FLUCTUATION 7 0.0006
219 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
220 SPINAL COLUMN STENOSIS 3 0.0006
221 THERAPEUTIC RESPONSE CHANGED 4 0.0006
222 BLOOD GLUCOSE DECREASED 30 0.0006
223 SKIN INFECTION 7 0.0006
224 PROCTALGIA 4 0.0006
225 CARDIAC FLUTTER 4 0.0006
226 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
227 VITAMIN D DEFICIENCY 6 0.0006
228 BACK DISORDER 10 0.0006
229 GASTROOESOPHAGEAL REFLUX DISEASE 49 0.0006
230 RESTLESS LEGS SYNDROME 11 0.0006
231 BLADDER DISORDER 6 0.0006
232 MUSCLE INJURY 5 0.0006
233 UPPER LIMB FRACTURE 12 0.0006
234 ANXIETY DISORDER 2 0.0006
235 HAIR TEXTURE ABNORMAL 8 0.0006
236 BLOOD GLUCOSE INCREASED 112 0.0006
237 COLITIS ISCHAEMIC 4 0.0006
238 PATHOLOGICAL FRACTURE 3 0.0006
239 PRODUCT LABEL ISSUE 4 0.0006
240 AMMONIA INCREASED 3 0.0006
241 DYSSTASIA 17 0.0006
242 FOOT FRACTURE 11 0.0006
243 JOINT EFFUSION 4 0.0006
244 BLOOD MAGNESIUM DECREASED 5 0.0006
245 MUSCLE STRAIN 5 0.0006
246 BURSITIS 7 0.0006
247 FEELING COLD 16 0.0006
248 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
249 EXTRASYSTOLES 4 0.0006
250 SENSITIVITY TO WEATHER CHANGE 3 0.0006
251 BLOOD TEST ABNORMAL 8 0.0006
252 HEAD INJURY 18 0.0006
253 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
254 HAND FRACTURE 4 0.0006
255 HAIR COLOUR CHANGES 7 0.0006
256 IMPAIRED WORK ABILITY 12 0.0006
257 FACIAL PAIN 5 0.0006
258 BLOOD CHOLESTEROL INCREASED 26 0.0006
259 STRESS FRACTURE 3 0.0006
260 PANIC REACTION 4 0.0006
261 GASTROENTERITIS VIRAL 10 0.0006
262 MUSCLE ATROPHY 7 0.0006
263 EYE PAIN 31 0.0005
264 INTENTIONAL UNDERDOSE 4 0.0005
265 UTERINE LEIOMYOMA 4 0.0005
266 NONSPECIFIC REACTION 3 0.0005
267 SINUSITIS 56 0.0005
268 INJECTION SITE NODULE 6 0.0005
269 INCREASED TENDENCY TO BRUISE 5 0.0005
270 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
271 NERVE COMPRESSION 5 0.0005
272 HIATUS HERNIA 7 0.0005
273 PULMONARY MASS 8 0.0005
274 NODULE 7 0.0005
275 GLOSSODYNIA 12 0.0005
276 FLANK PAIN 5 0.0005
277 SQUAMOUS CELL CARCINOMA 5 0.0005
278 DYSPHONIA 31 0.0005
279 TROPONIN INCREASED 4 0.0005
280 DIABETES MELLITUS 40 0.0005
281 PRODUCTIVE COUGH 25 0.0005
282 NEPHROLITHIASIS 24 0.0005
283 SINUS CONGESTION 7 0.0005
284 HYPERCHOLESTEROLAEMIA 5 0.0005
285 PSORIATIC ARTHROPATHY 21 0.0005
286 CONCUSSION 4 0.0005
287 RALES 3 0.0005
288 LOCAL SWELLING 9 0.0005
289 JOINT INJURY 11 0.0005
290 EAR PAIN 10 0.0005
291 MUSCULOSKELETAL STIFFNESS 45 0.0005
292 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
293 HYPERCHLORHYDRIA 3 0.0005
294 HEPATOMEGALY 5 0.0005
295 KNEE OPERATION 5 0.0005
296 PRODUCT USE COMPLAINT 8 0.0005
297 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
298 PERIPHERAL SWELLING 78 0.0005
299 FURUNCLE 4 0.0005
300 CYSTITIS 16 0.0005
301 ACCIDENT 6 0.0005
302 DIPLOPIA 13 0.0005
303 SPINAL FRACTURE 10 0.0005
304 CANDIDIASIS 2 0.0005
305 BLEPHARITIS 2 0.0005
306 SENSORY LOSS 4 0.0005
307 FRUSTRATION TOLERANCE DECREASED 4 0.0005
308 NOCTURIA 6 0.0005
309 MUSCLE DISORDER 4 0.0005
310 BLOOD POTASSIUM INCREASED 8 0.0005
311 COGNITIVE DISORDER 23 0.0005
312 DRY THROAT 5 0.0005
313 FEELING HOT 30 0.0005
314 HYPERSOMNIA 14 0.0005
315 CONTUSION 47 0.0005
316 WEIGHT DECREASED 136 0.0005
317 CATARACT 29 0.0005
318 STAPHYLOCOCCAL INFECTION 16 0.0005
319 CYST 6 0.0005
320 PAIN OF SKIN 13 0.0005
321 ATRIAL FIBRILLATION 47 0.0005
322 INFUSION SITE EXTRAVASATION 3 0.0005
323 CONSTIPATION 105 0.0005
324 HEMIPLEGIA 4 0.0005
325 GAIT DISTURBANCE 92 0.0005
326 PRE-EXISTING CONDITION IMPROVED 3 0.0005
327 MEMORY IMPAIRMENT 66 0.0005
328 LIMB INJURY 13 0.0005
329 DYSPNOEA EXERTIONAL 18 0.0005
330 BLOOD UREA INCREASED 8 0.0005
331 INFUSION SITE SWELLING 3 0.0005
332 AMNESIA 31 0.0005
333 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
334 INFUSION SITE ERYTHEMA 4 0.0005
335 SKIN HAEMORRHAGE 7 0.0005
336 FOREIGN BODY SENSATION IN EYES 3 0.0005
337 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
338 IMMUNODEFICIENCY 7 0.0005
339 ABSCESS LIMB 2 0.0005
340 DIVERTICULITIS 13 0.0005
341 RETCHING 10 0.0005
342 THERAPY CESSATION 24 0.0005
343 ALCOHOLISM 2 0.0005
344 BLOOD POTASSIUM DECREASED 14 0.0005
345 CARDIAC OPERATION 4 0.0005
346 ABNORMAL SENSATION IN EYE 2 0.0005
347 NECK PAIN 26 0.0005
348 DECREASED ACTIVITY 5 0.0005
349 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
350 BONE CANCER 2 0.0005
351 BACK INJURY 5 0.0005
352 BRADYPHRENIA 3 0.0005
353 KIDNEY INFECTION 9 0.0005
354 INSURANCE ISSUE 7 0.0005
355 PARAESTHESIA 72 0.0005
356 NAIL DISORDER 4 0.0005
357 HIP ARTHROPLASTY 7 0.0005
358 WOUND INFECTION 5 0.0005
359 BURNING SENSATION 32 0.0005
360 GROIN PAIN 4 0.0005
361 EPISTAXIS 34 0.0005
362 APPLICATION SITE PAIN 10 0.0005
363 MENTAL IMPAIRMENT 11 0.0005
364 PRESYNCOPE 11 0.0005
365 CATHETERISATION CARDIAC 2 0.0005
366 EYE HAEMORRHAGE 6 0.0004
367 OSTEOARTHRITIS 19 0.0004
368 CHOLECYSTITIS CHRONIC 3 0.0004
369 THIRST 8 0.0004
370 DYSPEPSIA 44 0.0004
371 BREAST MASS 3 0.0004
372 THROAT IRRITATION 20 0.0004
373 OCULAR DISCOMFORT 5 0.0004
374 LOSS OF LIBIDO 4 0.0004
375 ANAL INCONTINENCE 4 0.0004
376 OROPHARYNGEAL PAIN 41 0.0004
377 HEART RATE IRREGULAR 10 0.0004
378 REBOUND EFFECT 5 0.0004
379 FALL 147 0.0004
380 AGEUSIA 11 0.0004
381 IMPAIRED DRIVING ABILITY 5 0.0004
382 URINARY TRACT INFECTION 75 0.0004
383 INSOMNIA 117 0.0004
384 END STAGE RENAL DISEASE 8 0.0004
385 BLOOD TESTOSTERONE DECREASED 3 0.0004
386 HYPOTHYROIDISM 14 0.0004
387 GASTRIC HAEMORRHAGE 5 0.0004
388 HAIR GROWTH ABNORMAL 3 0.0004
389 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
390 LARGE INTESTINE POLYP 3 0.0004
391 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
392 BACK PAIN 100 0.0004
393 COORDINATION ABNORMAL 6 0.0004
394 MIDDLE INSOMNIA 8 0.0004
395 DEFAECATION URGENCY 3 0.0004
396 PHOTOPHOBIA 8 0.0004
397 MUSCLE SPASMS 78 0.0004
398 ABDOMINAL DISCOMFORT 71 0.0004
399 VISION BLURRED 58 0.0004
400 COLITIS MICROSCOPIC 2 0.0004
401 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
402 ATAXIA 5 0.0004
403 RETINAL HAEMORRHAGE 3 0.0004
404 PAIN IN EXTREMITY 124 0.0004
405 FUNGAL INFECTION 14 0.0004
406 FEELING JITTERY 8 0.0004
407 IRRITABLE BOWEL SYNDROME 9 0.0004
408 RED BLOOD CELL COUNT DECREASED 12 0.0004
409 URINARY RETENTION 14 0.0004
410 BRONCHITIS 31 0.0004
411 GASTRITIS 11 0.0004
412 RHINORRHOEA 27 0.0004
413 WRIST FRACTURE 5 0.0004
414 PRODUCT SUBSTITUTION ISSUE 24 0.0004
415 BLOOD PRESSURE FLUCTUATION 10 0.0004
416 VISUAL FIELD DEFECT 3 0.0004
417 FAECES DISCOLOURED 9 0.0004
418 HERNIA 8 0.0004
419 ERUCTATION 8 0.0004
420 SKIN DISCOLOURATION 19 0.0004
421 HYPOKINESIA 6 0.0004
422 FEELING ABNORMAL 99 0.0004
423 INFLUENZA LIKE ILLNESS 34 0.0004
424 BLOOD PRESSURE INCREASED 63 0.0004
425 MYALGIA 70 0.0004
426 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
427 ORAL DISORDER 3 0.0004
428 FEAR 11 0.0004
429 RENAL TUBULAR NECROSIS 4 0.0004
430 RENAL DISORDER 19 0.0004
431 MUSCLE SPASTICITY 5 0.0004
432 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
433 THERAPY CHANGE 4 0.0004
434 APPLICATION SITE BURN 2 0.0004
435 SPINAL OPERATION 5 0.0004
436 HOSPICE CARE 4 0.0004
437 ABASIA 10 0.0004
438 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
439 NIGHT SWEATS 13 0.0004
440 PHARYNGITIS 5 0.0004
441 APPLICATION SITE SWELLING 2 0.0004
442 SNEEZING 9 0.0004
443 OVARIAN CYST 4 0.0004
444 FATIGUE 311 0.0004
445 THROMBOSIS 32 0.0004
446 TENDON PAIN 3 0.0004
447 AORTIC ANEURYSM 3 0.0004
448 EYELID PTOSIS 4 0.0004
449 FLUID RETENTION 20 0.0004
450 ACIDOSIS 3 0.0004
451 BOWEL MOVEMENT IRREGULARITY 3 0.0004
452 LIPASE INCREASED 3 0.0004
453 DYSGEUSIA 29 0.0004
454 ASTHENIA 146 0.0004
455 INFUSION SITE PAIN 5 0.0004
456 DECREASED APPETITE 90 0.0004
457 TOOTHACHE 7 0.0004
458 LUNG INFECTION 6 0.0004
459 PELVIC FRACTURE 3 0.0004
460 ARTHRALGIA 160 0.0004
461 BASAL CELL CARCINOMA 6 0.0004
462 BONE DISORDER 7 0.0004
463 POLLAKIURIA 16 0.0004
464 HEART RATE INCREASED 38 0.0004
465 PLATELET COUNT INCREASED 5 0.0004
466 PRODUCT ODOUR ABNORMAL 4 0.0004
467 TRANSFUSION 4 0.0004
468 MUSCULOSKELETAL PAIN 20 0.0004
469 SPEECH DISORDER 20 0.0004
470 APPLICATION SITE ERYTHEMA 10 0.0004
471 ARTHRITIS 30 0.0004
472 JOINT STIFFNESS 10 0.0004
473 DRUG DOSE OMISSION 63 0.0004
474 HYPOAESTHESIA 57 0.0004
475 KNEE ARTHROPLASTY 8 0.0004
476 IMMUNE SYSTEM DISORDER 5 0.0004
477 GASTRIC DISORDER 13 0.0004
478 NASAL DISCOMFORT 3 0.0004
479 JOINT DISLOCATION 4 0.0004
480 RENAL CYST 3 0.0004
481 OBESITY 6 0.0004
482 EYE SWELLING 14 0.0004
483 ANORECTAL DISCOMFORT 2 0.0004
484 BONE PAIN 22 0.0004
485 HEADACHE 235 0.0004
486 NASAL CONGESTION 22 0.0004
487 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
488 RHINITIS 3 0.0004
489 DIARRHOEA 240 0.0004
490 POOR QUALITY SLEEP 8 0.0004
491 BLOOD SODIUM DECREASED 7 0.0004
492 ANAL ABSCESS 2 0.0004
493 BRUXISM 2 0.0004
494 FIBROMYALGIA 9 0.0004
495 PRURITUS GENERALISED 8 0.0004
496 DRY MOUTH 30 0.0004
497 ERYTHEMA 76 0.0004
498 RENAL FAILURE 49 0.0004
499 SLEEP DISORDER 26 0.0004
500 BIPOLAR DISORDER 4 0.0004
501 SKIN LACERATION 4 0.0004
502 MUSCULOSKELETAL DISORDER 7 0.0004
503 HEPATIC ENZYME INCREASED 25 0.0004
504 MIGRAINE 35 0.0004
505 GINGIVAL BLEEDING 5 0.0004
506 HYPERAESTHESIA 3 0.0004
507 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
508 CORONARY ARTERY OCCLUSION 5 0.0004
509 SKIN LESION 10 0.0004
510 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
511 NERVOUSNESS 19 0.0004
512 CARDIAC DISORDER 34 0.0004
513 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
514 TOOTH FRACTURE 4 0.0004
515 PRURITUS 139 0.0004
516 OEDEMA PERIPHERAL 44 0.0004
517 VERTIGO 22 0.0004
518 LIVER DISORDER 16 0.0004
519 DRY EYE 18 0.0004
520 ORAL DISCOMFORT 5 0.0004
521 GAIT INABILITY 12 0.0004
522 CHOKING 7 0.0004
523 SKIN FISSURES 7 0.0004
524 MASS 5 0.0004
525 DIZZINESS 178 0.0004
526 SENSATION OF FOREIGN BODY 3 0.0004
527 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
528 FEMUR FRACTURE 11 0.0004
529 INTENTIONAL PRODUCT MISUSE 31 0.0004
530 MITRAL VALVE INCOMPETENCE 4 0.0004
531 DYSURIA 13 0.0004
532 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
533 HYPOPHAGIA 9 0.0004
534 MUSCULAR WEAKNESS 40 0.0004
535 CHEST DISCOMFORT 36 0.0004
536 SCAR 6 0.0004
537 INTERNAL HAEMORRHAGE 4 0.0003
538 MUSCULOSKELETAL DISCOMFORT 6 0.0003
539 MOBILITY DECREASED 25 0.0003
540 VISUAL IMPAIRMENT 43 0.0003
541 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
542 CARDIAC MURMUR 3 0.0003
543 STOMATITIS 21 0.0003
544 COUGH 97 0.0003
545 RESPIRATORY TRACT INFECTION 9 0.0003
546 CHEST PAIN 64 0.0003
547 MADAROSIS 4 0.0003
548 URINE OUTPUT DECREASED 3 0.0003
549 SPLENOMEGALY 4 0.0003
550 SPINAL PAIN 4 0.0003
551 IMMUNOSUPPRESSION 3 0.0003
552 SOMNOLENCE 68 0.0003
553 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 24 0.0003
554 PRODUCT DOSE OMISSION 22 0.0003
555 GALLBLADDER DISORDER 6 0.0003
556 CARDIAC PACEMAKER INSERTION 2 0.0003
557 IMPAIRED HEALING 11 0.0003
558 MACULAR DEGENERATION 4 0.0003
559 GASTROINTESTINAL INFECTION 3 0.0003
560 EYE DISORDER 11 0.0003
561 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
562 BLOOD PRESSURE DECREASED 22 0.0003
563 LACRIMATION INCREASED 10 0.0003
564 WEIGHT INCREASED 74 0.0003
565 DRUG EFFECT INCOMPLETE 12 0.0003
566 LETHARGY 19 0.0003
567 OPTIC NEURITIS 3 0.0003
568 ECONOMIC PROBLEM 5 0.0003
569 BLOOD COUNT ABNORMAL 5 0.0003
570 OSTEOPENIA 5 0.0003
571 RECTAL HAEMORRHAGE 14 0.0003
572 INJECTION SITE HAEMORRHAGE 26 0.0003
573 TREMOR 54 0.0003
574 ANGER 11 0.0003
575 CARDIOMEGALY 4 0.0003
576 UROSEPSIS 3 0.0003
577 INJECTION SITE MASS 12 0.0003
578 HYPERCALCAEMIA 4 0.0003
579 LIMB DISCOMFORT 10 0.0003
580 ANKLE FRACTURE 5 0.0003
581 PERSONALITY CHANGE 3 0.0003
582 HEPATIC STEATOSIS 6 0.0003
583 NEPHROPATHY 3 0.0003
584 SKIN BURNING SENSATION 23 0.0003
585 DIARRHOEA HAEMORRHAGIC 3 0.0003
586 ACUTE KIDNEY INJURY 49 0.0003
587 INJECTION SITE DISCOLOURATION 4 0.0003
588 SKIN EXFOLIATION 27 0.0003
589 LACERATION 3 0.0003
590 BLEPHAROSPASM 2 0.0003
591 DEPRESSION 72 0.0003
592 SPUTUM DISCOLOURED 3 0.0003
593 IRRITABILITY 19 0.0003
594 TOOTH DISORDER 7 0.0003
595 DRY SKIN 42 0.0003
596 ABSCESS 5 0.0003
597 ORAL PAIN 7 0.0003
598 POST PROCEDURAL COMPLICATION 6 0.0003
599 GLAUCOMA 6 0.0003
600 SENSORY DISTURBANCE 5 0.0003
601 HIP FRACTURE 10 0.0003
602 ABDOMINAL PAIN UPPER 64 0.0003
603 CHROMATURIA 7 0.0003
604 PRESCRIBED OVERDOSE 6 0.0003
605 MUSCLE TIGHTNESS 5 0.0003
606 APPLICATION SITE VESICLES 2 0.0003
607 AUTOIMMUNE DISORDER 3 0.0003
608 ANGINA UNSTABLE 2 0.0003
609 INFLAMMATORY BOWEL DISEASE 3 0.0003
610 ARTHROPATHY 17 0.0003
611 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
612 METASTASES TO BONE 5 0.0003
613 PAIN 187 0.0003
614 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
615 PHOTOSENSITIVITY REACTION 5 0.0003
616 DEPRESSED MOOD 16 0.0003
617 VIRAL INFECTION 10 0.0003
618 COAGULOPATHY 5 0.0003
619 PALPITATIONS 35 0.0003
620 MALIGNANT MELANOMA 4 0.0003
621 QUALITY OF LIFE DECREASED 4 0.0003
622 HYPERTENSION 63 0.0003
623 EMPHYSEMA 3 0.0003
624 DISTURBANCE IN ATTENTION 16 0.0003
625 CANDIDA INFECTION 5 0.0003
626 HERPES ZOSTER 17 0.0003
627 PLEURAL EFFUSION 18 0.0003
628 DYSKINESIA 12 0.0003
629 HYPERHIDROSIS 38 0.0003
630 TOOTH ABSCESS 3 0.0003
631 SLUGGISHNESS 3 0.0003
632 ABNORMAL LOSS OF WEIGHT 2 0.0003
633 MOOD ALTERED 8 0.0003
634 NEUTROPHIL COUNT INCREASED 3 0.0003
635 MULTIPLE SCLEROSIS 14 0.0003
636 DYSARTHRIA 11 0.0003
637 RIB FRACTURE 6 0.0003
638 CONFUSIONAL STATE 47 0.0003
639 PNEUMONIA 94 0.0003
640 JOINT SWELLING 35 0.0003
641 ABNORMAL DREAMS 8 0.0003
642 HUNGER 4 0.0003
643 ORTHOSTATIC HYPOTENSION 5 0.0003
644 APHONIA 4 0.0003
645 CARDIAC FAILURE CONGESTIVE 23 0.0003
646 LYMPHOCYTE COUNT DECREASED 5 0.0003
647 PAIN IN JAW 8 0.0003
648 MOOD SWINGS 9 0.0003
649 CHILLS 33 0.0003
650 SUBDURAL HAEMATOMA 4 0.0003
651 IMPAIRED QUALITY OF LIFE 4 0.0003
652 UNEVALUABLE EVENT 21 0.0003
653 ANOSMIA 4 0.0003
654 OSTEOMYELITIS 5 0.0003
655 MENTAL DISORDER 12 0.0003
656 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
657 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
658 NEEDLE ISSUE 8 0.0003
659 APATHY 4 0.0003
660 HAEMOGLOBIN DECREASED 28 0.0003
661 ERECTILE DYSFUNCTION 7 0.0003
662 PLATELET COUNT DECREASED 29 0.0003
663 HAEMATOCHEZIA 15 0.0003
664 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
665 LABORATORY TEST ABNORMAL 8 0.0003
666 SKIN ULCER 7 0.0003
667 CARDIOMYOPATHY 4 0.0003
668 RASH GENERALISED 7 0.0003
669 DYSPNOEA 153 0.0003
670 ARTHROPOD BITE 2 0.0003
671 SKIN DISORDER 9 0.0003
672 NERVE INJURY 3 0.0003
673 COLON CANCER 4 0.0003
674 THINKING ABNORMAL 5 0.0003
675 MALNUTRITION 3 0.0003
676 NAUSEA 212 0.0003
677 RASH PAPULAR 6 0.0003
678 RESPIRATORY DISORDER 8 0.0003
679 PANCREATITIS ACUTE 6 0.0003
680 BLOOD CALCIUM DECREASED 3 0.0003
681 THERAPY INTERRUPTED 19 0.0003
682 NASOPHARYNGITIS 49 0.0003
683 PANCREATITIS 14 0.0003
684 APPLICATION SITE PRURITUS 6 0.0003
685 CORONARY ARTERY DISEASE 8 0.0003
686 RASH 115 0.0003
687 MICTURITION URGENCY 3 0.0003
688 CHOLECYSTECTOMY 3 0.0003
689 COVID-19 46 0.0003
690 WITHDRAWAL SYNDROME 11 0.0003
691 PSORIASIS 34 0.0003
692 LOWER LIMB FRACTURE 5 0.0003
693 NIGHTMARE 9 0.0003
694 ACUTE RESPIRATORY FAILURE 5 0.0003
695 DRUG EFFECT DECREASED 14 0.0003
696 DEVICE RELATED INFECTION 4 0.0003
697 THYROID DISORDER 4 0.0003
698 EMOTIONAL DISORDER 8 0.0003
699 ATRIOVENTRICULAR BLOCK 2 0.0003
700 RASH PRURITIC 14 0.0003
701 APHTHOUS ULCER 2 0.0003
702 POST PROCEDURAL HAEMORRHAGE 3 0.0003
703 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
704 EJECTION FRACTION DECREASED 4 0.0003
705 APNOEA 2 0.0003
706 SWELLING 24 0.0003
707 HEART RATE DECREASED 9 0.0003
708 DEVICE MALFUNCTION 18 0.0003
709 SURGERY 15 0.0003
710 BRAIN FOG 4 0.0003
711 DEHYDRATION 34 0.0003
712 ALOPECIA 50 0.0003
713 COVID-19 PNEUMONIA 3 0.0003
714 CEREBROVASCULAR ACCIDENT 43 0.0003
715 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
716 OCULAR HYPERAEMIA 12 0.0003
717 BLOOD IRON DECREASED 3 0.0003
718 BLOOD ALBUMIN DECREASED 2 0.0003
719 PRODUCT PRESCRIBING ERROR 6 0.0003
720 RESPIRATORY TRACT CONGESTION 4 0.0003
721 ULCER 4 0.0003
722 INJECTION SITE BRUISING 20 0.0003
723 ATRIAL FLUTTER 2 0.0003
724 PRESCRIBED UNDERDOSE 5 0.0003
725 WOUND 7 0.0003
726 PRODUCT QUALITY ISSUE 34 0.0003
727 DIABETIC KETOACIDOSIS 6 0.0002
728 MOVEMENT DISORDER 8 0.0002
729 MALAISE 109 0.0002
730 PRODUCT ADMINISTRATION ERROR 5 0.0002
731 TASTE DISORDER 5 0.0002
732 ABNORMAL FAECES 2 0.0002
733 CHOLELITHIASIS 8 0.0002
734 TENDON RUPTURE 3 0.0002
735 ANXIETY 69 0.0002
736 GENERALISED OEDEMA 3 0.0002
737 INFECTION 35 0.0002
738 APPLICATION SITE IRRITATION 3 0.0002
739 SUICIDAL IDEATION 22 0.0002
740 TINNITUS 11 0.0002
741 ROAD TRAFFIC ACCIDENT 10 0.0002
742 RENAL INJURY 7 0.0002
743 ADVERSE DRUG REACTION 21 0.0002
744 MULTIPLE SCLEROSIS RELAPSE 16 0.0002
745 ILLNESS 24 0.0002
746 PARANOIA 4 0.0002
747 INJECTION SITE INDURATION 3 0.0002
748 DEEP VEIN THROMBOSIS 15 0.0002
749 WHITE BLOOD CELL COUNT DECREASED 25 0.0002
750 NEOPLASM PROGRESSION 8 0.0002
751 PRODUCT DISPENSING ERROR 5 0.0002
752 DRUG ADMINISTRATION ERROR 7 0.0002
753 DRUG INTOLERANCE 22 0.0002
754 PULMONARY CONGESTION 3 0.0002
755 MELAENA 5 0.0002
756 SARS-COV-2 TEST POSITIVE 3 0.0002
757 LYMPHADENOPATHY 8 0.0002
758 EYE IRRITATION 13 0.0002
759 EAR INFECTION 6 0.0002
760 NERVOUS SYSTEM DISORDER 7 0.0002
761 SWOLLEN TONGUE 7 0.0002
762 INJECTION SITE PRURITUS 15 0.0002
763 JOINT RANGE OF MOTION DECREASED 3 0.0002
764 PRODUCT TASTE ABNORMAL 3 0.0002
765 CRYING 8 0.0002
766 HYPERGLYCAEMIA 8 0.0002
767 ABDOMINAL PAIN 51 0.0002
768 OSTEOPOROSIS 9 0.0002
769 PERIPHERAL COLDNESS 3 0.0002
770 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
771 APPLICATION SITE RASH 3 0.0002
772 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
773 MUSCLE TWITCHING 5 0.0002
774 SEPSIS 24 0.0002
775 HAEMOPTYSIS 6 0.0002
776 BLOOD CREATININE INCREASED 14 0.0002
777 RENAL IMPAIRMENT 18 0.0002
778 BLISTER 12 0.0002
779 OXYGEN SATURATION DECREASED 12 0.0002
780 INFLAMMATION 11 0.0002
781 BLINDNESS UNILATERAL 3 0.0002
782 ARTERIOSCLEROSIS 2 0.0002
783 HALLUCINATION 16 0.0002
784 FRACTURE 4 0.0002
785 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
786 DYSPHAGIA 20 0.0002
787 EXPIRED PRODUCT ADMINISTERED 7 0.0002
788 GASTRIC ULCER 4 0.0002
789 PARALYSIS 3 0.0002
790 ANGINA PECTORIS 6 0.0002
791 RASH ERYTHEMATOUS 10 0.0002
792 EYE PRURITUS 7 0.0002
793 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
794 MYELODYSPLASTIC SYNDROME 3 0.0002
795 INFLUENZA 23 0.0002
796 ADVERSE EVENT 19 0.0002
797 FLUID OVERLOAD 3 0.0002
798 NEURALGIA 5 0.0002
799 GASTROENTERITIS 3 0.0002
800 ORAL HERPES 4 0.0002
801 HAEMATURIA 7 0.0002
802 AGITATION 15 0.0002
803 VOMITING 96 0.0002
804 PRODUCT DOSE OMISSION ISSUE 60 0.0002
805 LOSS OF CONSCIOUSNESS 26 0.0002
806 OEDEMA 11 0.0002
807 DISABILITY 4 0.0002
808 INJECTION SITE PAIN 62 0.0002
809 ABDOMINAL DISTENSION 21 0.0002
810 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
811 HAEMORRHAGE INTRACRANIAL 3 0.0002
812 BRAIN INJURY 2 0.0002
813 HYPERSENSITIVITY 37 0.0002
814 APHASIA 6 0.0002
815 FEEDING DISORDER 4 0.0002
816 URTICARIA 33 0.0002
817 DISCOMFORT 12 0.0002
818 BLINDNESS 8 0.0002
819 DRUG DISPENSING ERROR 3 0.0002
820 NEUTROPHIL COUNT DECREASED 8 0.0002
821 LYMPHOMA 3 0.0002
822 ANAEMIA 37 0.0002
823 INJECTION SITE ERYTHEMA 24 0.0002
824 DELUSION 3 0.0002
825 PANIC ATTACK 7 0.0002
826 PULMONARY HYPERTENSION 4 0.0002
827 INTENTIONAL DRUG MISUSE 4 0.0002
828 RESTLESSNESS 7 0.0002
829 DEAFNESS 5 0.0002
830 ECZEMA 10 0.0002
831 DERMATITIS 4 0.0002
832 SYNCOPE 19 0.0002
833 DISEASE RECURRENCE 9 0.0002
834 BREAST PAIN 2 0.0002
835 HYPOACUSIS 8 0.0002
836 HYPOGLYCAEMIA 9 0.0002
837 THROAT TIGHTNESS 5 0.0002
838 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
839 SWELLING FACE 12 0.0002
840 INCORRECT DOSE ADMINISTERED 42 0.0002
841 PALLOR 5 0.0002
842 LIP SWELLING 6 0.0002
843 STEVENS-JOHNSON SYNDROME 4 0.0002
844 PULMONARY OEDEMA 8 0.0002
845 CELLULITIS 9 0.0002
846 UNDERDOSE 13 0.0002
847 MYOCARDIAL INFARCTION 31 0.0002
848 ASTHMA 20 0.0002
849 PYREXIA 61 0.0002
850 RHEUMATOID ARTHRITIS 20 0.0002
851 PRODUCT USE ISSUE 33 0.0002
852 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
853 EXTRA DOSE ADMINISTERED 7 0.0002
854 HAEMORRHAGE 18 0.0002
855 RASH MACULAR 6 0.0002
856 METASTASES TO LIVER 3 0.0002
857 HEAD DISCOMFORT 3 0.0002
858 ARRHYTHMIA 8 0.0002
859 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
860 BACTERAEMIA 2 0.0002
861 CHOLECYSTITIS 2 0.0002
862 GASTROINTESTINAL DISORDER 15 0.0002
863 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
864 LUNG DISORDER 8 0.0002
865 INJECTION SITE RASH 5 0.0002
866 ENCEPHALOPATHY 4 0.0002
867 MEDICATION ERROR 9 0.0002
868 CONDITION AGGRAVATED 49 0.0002
869 COLITIS 6 0.0002
870 ABDOMINAL PAIN LOWER 4 0.0002
871 PRODUCT COMPLAINT 4 0.0002
872 DRUG INTERACTION 25 0.0002
873 DRUG PRESCRIBING ERROR 3 0.0002
874 THERAPY NON-RESPONDER 7 0.0002
875 ANAPHYLACTIC SHOCK 4 0.0002
876 HAEMATOMA 4 0.0002
877 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
878 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
879 BEDRIDDEN 2 0.0002
880 ABNORMAL BEHAVIOUR 6 0.0002
881 HAEMATOCRIT DECREASED 3 0.0002
882 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
883 NEOPLASM MALIGNANT 10 0.0001
884 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
885 INJECTION SITE WARMTH 3 0.0001
886 ACNE 11 0.0001
887 DRUG INEFFECTIVE 191 0.0001
888 PROCEDURAL PAIN 4 0.0001
889 MENTAL STATUS CHANGES 4 0.0001
890 MOUTH ULCERATION 3 0.0001
891 INJURY 10 0.0001
892 HALLUCINATION, VISUAL 3 0.0001
893 TARDIVE DYSKINESIA 4 0.0001
894 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
895 LIVER FUNCTION TEST INCREASED 3 0.0001
896 CEREBRAL HAEMORRHAGE 5 0.0001
897 ACCIDENTAL UNDERDOSE 2 0.0001
898 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 25 0.0001
899 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
900 VAGINAL HAEMORRHAGE 6 0.0001
901 PULMONARY EMBOLISM 13 0.0001
902 ACCIDENTAL OVERDOSE 5 0.0001
903 ASCITES 4 0.0001
904 WHEEZING 8 0.0001
905 PRODUCT USE IN UNAPPROVED INDICATION 33 0.0001
906 INTESTINAL OBSTRUCTION 5 0.0001
907 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
908 INJECTION SITE SWELLING 10 0.0001
909 PERICARDIAL EFFUSION 3 0.0001
910 HYPOTENSION 26 0.0001
911 ACUTE MYELOID LEUKAEMIA 2 0.0001
912 PLASMA CELL MYELOMA 5 0.0001
913 TREATMENT NONCOMPLIANCE 7 0.0001
914 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
915 DISORIENTATION 5 0.0001
916 HOSPITALISATION 19 0.0001
917 DEVICE ISSUE 11 0.0001
918 SEIZURE 14 0.0001
919 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
920 PNEUMONIA ASPIRATION 3 0.0001
921 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
922 HAEMATEMESIS 3 0.0001
923 DISEASE PROGRESSION 14 0.0001
924 RENAL FAILURE ACUTE 5 0.0001
925 OFF LABEL USE 102 0.0001
926 SEPTIC SHOCK 5 0.0001
927 MUCOSAL INFLAMMATION 3 0.0001
928 ANHEDONIA 3 0.0001
929 HYPOXIA 4 0.0001
930 TACHYCARDIA 10 0.0001
931 BLOOD BILIRUBIN INCREASED 3 0.0001
932 FREQUENT BOWEL MOVEMENTS 3 0.0001
933 C-REACTIVE PROTEIN INCREASED 4 0.0001
934 SKIN IRRITATION 5 0.0001
935 RESPIRATORY ARREST 3 0.0001
936 ANAPHYLACTIC REACTION 6 0.0001
937 HYPOKALAEMIA 5 0.0001
938 CONJUNCTIVITIS 2 0.0001
939 PANCYTOPENIA 6 0.0001
940 BREAST CANCER 10 0.0001
941 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
942 INFUSION RELATED REACTION 7 0.0001
943 INTENTIONAL DOSE OMISSION 3 0.0001
944 PANCREATIC CARCINOMA 3 0.0001
945 DRUG WITHDRAWAL SYNDROME 9 0.0001
946 ACUTE MYOCARDIAL INFARCTION 3 0.0001
947 SUICIDE ATTEMPT 6 0.0001
948 DEVICE BREAKAGE 4 0.0001
949 BODY TEMPERATURE INCREASED 2 0.0001
950 LUNG NEOPLASM MALIGNANT 4 0.0001
951 GYNAECOMASTIA 3 0.0001
952 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
953 DEVICE LEAKAGE 4 0.0001
954 COLITIS ULCERATIVE 4 0.0001
955 THROMBOCYTOPENIA 10 0.0001
956 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
957 DELIRIUM 3 0.0001
958 PRODUCT ADHESION ISSUE 3 0.0001
959 INTERSTITIAL LUNG DISEASE 4 0.0001
960 THERAPEUTIC RESPONSE DECREASED 5 0.0001
961 ILL-DEFINED DISORDER 5 0.0001
962 RESPIRATORY FAILURE 6 0.0001
963 LEUKOPENIA 4 0.0001
964 FEBRILE NEUTROPENIA 5 0.0001
965 INJECTION SITE REACTION 5 0.0001
966 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
967 BLADDER CANCER 4 0.0001
968 NEUTROPENIA 9 0.0001
969 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
970 CARDIAC FAILURE 5 0.0001
971 PROSTATE CANCER 5 0.0001
972 DEATH 53 0.0001
973 OVERDOSE 13 0.0001
974 BRADYCARDIA 3 0.0001
975 CONVULSION 3 0.0001
976 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
977 ABORTION SPONTANEOUS 2 0.0000
978 EMOTIONAL DISTRESS 6 0.0000
979 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
980 CARDIO-RESPIRATORY ARREST 2 0.0000
981 DEVICE DIFFICULT TO USE 3 0.0000
982 ANGIOEDEMA 2 0.0000
983 COMA 2 0.0000
984 AGGRESSION 2 0.0000
985 CARDIAC ARREST 3 0.0000
986 TOXICITY TO VARIOUS AGENTS 6 0.0000
987 NO ADVERSE EVENT 6 0.0000
988 DRUG DEPENDENCE 4 0.0000
989 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000